MEFFX
Price
$10.88
Change
+$0.02 (+0.18%)
Updated
Jun 2 closing price
Net Assets
2.58B
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

MEFFX vs PMBCX

Header iconMEFFX vs PMBCX Comparison
Open Charts MEFFX vs PMBCXBanner chart's image
MEFFX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
MEFFX vs. PMBCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEFFX is a Hold and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. MEFFX (2.58B). MEFFX (0.00) and PMBCX (0.00) have matching dividends . MEFFX was incepted earlier than PMBCX: MEFFX (12 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than MEFFX (1.13). MEFFX is a more actively managed with annual turnover of: 38.00 vs. PMBCX (13.70). MEFFX has a lower initial minimum investment than PMBCX: MEFFX (0) vs PMBCX (1000). PMBCX (-15.11) and MEFFX (-15.42) have marching annual gain over last year. PMBCX return over 5 years is better than : -9.16 vs. MEFFX (-55.26).
MEFFXPMBCXMEFFX / PMBCX
Total Expense Ratio1.111.7165%
Annual Report Gross Expense Ratio1.131.7166%
Fund Existence12 years19 years-
Gain YTD5.437-7.252-75%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.58B24.6B10%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.42-15.11102%
Returns for 3 years-21.899.97-220%
Returns for 5 years-55.26-9.16603%
Returns for 10 years-33.7953.20-64%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity